Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey

Turkish Journal of Gastroenterology

Volumn 24, Issue 4, 2013, Pages 349-355

  Altuǧlu, Imre ^a   Sertoz, Ruchan ^a   Aksoy, Ayflegul ^a   Gursel, Derya ^a   Tuzuner, Uǧur ^a   Gunşar, Fulya ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Genotype; Hepatitis C; Risk factors

Indexed keywords

ADULT; ARTICLE; DENTAL PROCEDURE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SURGICAL PATIENT; TURKEY (REPUBLIC); VIRUS TRANSMISSION;

ADULT; AGED; DENTAL PROPHYLAXIS; DNA, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SURGICAL PROCEDURES, OPERATIVE; TELEPHONE; TURKEY; YOUNG ADULT;

EID: 84886442403     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2013.0518     Document Type: Article

References (26)

1. Perz JF, Farrington LA, Pecoraro C, et al. Estimated global prevalence of hepatitis C virus infection. 42nd Annual Meeting of the Infectious Diseases Society of America; Boston, MA, USA; September 30-October 3, 2004.
2. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1-39.
3. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 1995; 23:273-7.
4. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36:106-13.
5. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36:99-105.
6. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21:570-83.
7. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa- 2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-82.
8. Chan SW, McOmish F, Holmes EC et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variant. J Gen Virol 1992; 73:1131-41.
9. McOmish F, Chan SW, Dow BC et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33:7-13. (Pubitemid 23040322)
10. McOmish F, Yap P, Dow BC et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884-92. (Pubitemid 24100056)
11. Abacioglu YH, Davidson F, Tuncer S et al. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995; 2:297-301.
12. Ozacar T, Altuglu I, Zeytinoglu A et al. Distribution of HCV genotypes in chronic hepatitis. Mikrobiyol Bul 2001; 35:451-8. (Pubitemid 33325495)
13. Bozdayi AM, Aslan N, Bozdayi G et al. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 2004; 149:2115-29. (Pubitemid 39508954)
14. Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in western Turkey. Int J Infec Dis 2008; 12:239-44. (Pubitemid 351539094)
15. Cantaloube JF, Gallian P, Attoui H, et al. Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from Southeastern France. J Clin Microbiol 2005; 43:3624-9. (Pubitemid 41129638)
16. Haushofer AC, Kopty C, Hauer R, et al. HCV genotypes and age distribution in patients of Vienna and surrounding areas.J Clin Virol 2001; 20:41-7. (Pubitemid 32037150)
17. Yildirim B, Tahan V, Ozaras R et al. Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci 2005; 50: 2352-5. (Pubitemid 43106393)
18. Karaca C, Cakaloglu Y, Demir K, Ozdil S. Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci 2006; 51:365-9.
19. Barut S, Barut S, Egri M. Healthcare related risk factors account fort he majority of HCV Transmissions in Middle Black Sea Region of Turkey: A case control study. Turkiye Klinikleri J Med Sci 2011; 31:142-7.
20. Des Jarlais DC, Diaz T, Perlis T et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003; 157: 467-71. (Pubitemid 36258602)
21. Murray JM, Law MG, Gao Z, Kaldor JM. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol 2003; 32:708-14. (Pubitemid 37304626)
22. Hibell B, Andersson B, Bjarnason T et al. The ESPAD report 2003. Alcohol and other drug use among students in 35 European countries. Available at:http://www.espad.org/documents/Espad/ESPADreports/The-2003-ESPAD-report.pdf.
23. Busch MP, Glynn SA, Stramer SL et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45:254-64. (Pubitemid 40180144)
24. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36:93-8.
25. Hwang LY, Kramer JR, Troisi Cet al. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology 2006; 44:341-51. (Pubitemid 44214873)
26. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41. (Pubitemid 46929498)